Ant Group’s AI Health Service AQ Upgrades PC Platform with DeepSearch for Evidence-Based Clinical Decision Support

Ant Group, Jack Ma's fintech giant, is quietly positioning itself as a healthcare AI powerhouse by embedding advanced clinical decision-support tools directly into personal computers, a move that could reshape how doctors diagnose patients across China and beyond. The upgrade to its AQ health service introduces DeepSearch, an AI system designed to surface evidence-based medical literature in real time—a capability that threatens to disrupt the traditional gatekeepers of medical information and potentially accelerate the diagnosis of rare diseases. With only two sources reporting the development, this announcement appears to be flying under the radar of major tech and healthcare investors, despite its implications for how artificial intelligence will mediate the relationship between doctors and patients.

Business Wire·Jan 20